These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9778190)

  • 1. Muscarinic cholinergic receptor measurements with [18F]FP-TZTP: control and competition studies.
    Carson RE; Kiesewetter DO; Jagoda E; Der MG; Herscovitch P; Eckelman WC
    J Cereb Blood Flow Metab; 1998 Oct; 18(10):1130-42. PubMed ID: 9778190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and APOE-epsilon4 genotype influence the effect of physostigmine infusion on the in-vivo distribution volume of the muscarinic-2-receptor dependent tracer [18F]FP-TZTP.
    Cohen RM; Carson RE; Filbey F; Szczepanik J; Sunderland T
    Synapse; 2006 Jul; 60(1):86-92. PubMed ID: 16598702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo muscarinic 2 receptor imaging in cognitively normal young and older volunteers.
    Podruchny TA; Connolly C; Bokde A; Herscovitch P; Eckelman WC; Kiesewetter DO; Sunderland T; Carson RE; Cohen RM
    Synapse; 2003 Apr; 48(1):39-44. PubMed ID: 12557271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo muscarinic binding of 3-(alkylthio)-3-thiadiazolyl tetrahydropyridines.
    Kiesewetter DO; Carson RE; Jagoda EM; Herscovitch P; Eckelman WC
    Synapse; 1999 Jan; 31(1):29-40. PubMed ID: 10025681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of the muscarinic acetylcholine neuroreceptor in rats with the M2 selective agonist [18F]FP-TZTP.
    Ravasi L; Tokugawa J; Nakayama T; Seidel J; Sokoloff L; Eckelman WC; Kiesewetter DO
    Nucl Med Biol; 2012 Jan; 39(1):45-55. PubMed ID: 21831648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET.
    Reid AE; Ding YS; Eckelman WC; Logan J; Alexoff D; Shea C; Xu Y; Fowler JS
    Nucl Med Biol; 2008 Apr; 35(3):287-98. PubMed ID: 18355684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of [18F]FP-TZTP binding by loading doses of muscarinic agonists P-TZTP or FP-TZTP in vivo is not due to agonist-induced reduction in cerebral blood flow.
    Shimoji K; Esaki T; Itoh Y; Ravasi L; Cook M; Jehle J; Jagoda EM; Kiesewetter DO; Schmidt K; Sokoloff L; Eckelman WC
    Synapse; 2003 Nov; 50(2):151-63. PubMed ID: 12923818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential cholinergic mechanism of procaine's limbic activation.
    Benson BE; Carson RE; Kiesewetter DO; Herscovitch P; Eckelman WC; Post RM; Ketter TA
    Neuropsychopharmacology; 2004 Jul; 29(7):1239-50. PubMed ID: 14997171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor?
    Ravasi L; Kiesewetter DO; Shimoji K; Lucignani G; Eckelman WC
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):292-300. PubMed ID: 16333673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice.
    Jagoda EM; Kiesewetter DO; Shimoji K; Ravasi L; Yamada M; Gomeza J; Wess J; Eckelman WC
    Neuropharmacology; 2003 Apr; 44(5):653-61. PubMed ID: 12668051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of physostigmine and galantamine on the binding of [18F]fluoro-A-85380: a PET study in monkeys.
    Valette H; Bottlaender M; Dollé F; Coulon C; Ottaviani M; Syrota A
    Synapse; 2005 Jun; 56(4):217-21. PubMed ID: 15803498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors.
    Skaddan MB; Kilbourn MR; Snyder SE; Sherman PS
    J Cereb Blood Flow Metab; 2001 Feb; 21(2):144-8. PubMed ID: 11176279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive estimation of normalized distribution volume: application to the muscarinic-2 ligand [(18)F]FP-TZTP.
    Ichise M; Cohen RM; Carson RE
    J Cereb Blood Flow Metab; 2008 Feb; 28(2):420-30. PubMed ID: 17653129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of repeated measures of cholinergic terminal density using.
    Gage HD; Voytko ML; Ehrenkaufer RL; Tobin JR; Efange SM; Mach RH
    J Nucl Med; 2000 Dec; 41(12):2069-76. PubMed ID: 11138694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys.
    Kakiuchi T; Ohba H; Nishiyama S; Sato K; Harada N; Nakanishi S; Tsukada H
    Brain Res; 2001 Oct; 916(1-2):22-31. PubMed ID: 11597587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo muscarinic binding selectivity of (R,S)- and (R,R)-[18F]-fluoromethyl QNB.
    Kiesewetter DO; Carson RE; Jagoda EM; Endres CJ; Der MG; Herscovitch P; Eckelman WC
    Bioorg Med Chem; 1997 Aug; 5(8):1555-67. PubMed ID: 9313861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
    Easwaramoorthy B; Pichika R; Collins D; Potkin SG; Leslie FM; Mukherjee J
    Synapse; 2007 Jan; 61(1):29-36. PubMed ID: 17068780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man.
    Farde L; Suhara T; Halldin C; Nybäck H; Nakashima Y; Swahn CG; Karlsson P; Ginovart N; Bymaster FP; Shannon HE; Foged C; Suzdak PD; Sauerberg P
    Dementia; 1996; 7(4):187-95. PubMed ID: 8835881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher in vivo muscarinic-2 receptor distribution volumes in aging subjects with an apolipoprotein E-epsilon4 allele.
    Cohen RM; Podruchny TA; Bokde AL; Carson RE; Herscovitch P; Kiesewetter DO; Eckelman WC; Sunderland T
    Synapse; 2003 Sep; 49(3):150-6. PubMed ID: 12774299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.